CEVAC IBIRD LYOPHILISATE FOR OCULONASAL SUSPENSION/ USE IN DRINKING WATER FOR CHICKENS
CEVAC IBIRD LYOPHILISATE FOR OCULONASAL SUSPENSION/ USE IN DRINKING WATER FOR CHICKENS
Authorised
- Infectious bronchitis virus, type 793/B, strain 1/96, Live
Product identification
Medicine name:
CEVAC IBIRD LYOPHILISATE FOR OCULONASAL SUSPENSION/ USE IN DRINKING WATER FOR CHICKENS
Active substance:
- Infectious bronchitis virus, type 793/B, strain 1/96, Live
Target species:
-
Chicken (layer hen)
-
Chicken (broiler)
Route of administration:
-
Oculonasal use
-
Oral use
Product details
Active substance and strength:
-
Infectious bronchitis virus, type 793/B, strain 1/96, Live2.80/log 10 50% embryo infective dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
-
Oculonasal use
-
Chicken (layer hen)
-
All relevant tissues0day
-
-
Chicken (broiler)
-
All relevant tissues0day
-
-
-
Oral use
-
Chicken (layer hen)
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva-Phylaxia Zrt.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V441664
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0245/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 14/04/2025
eu-puar-frv0245001-mr-rpe774-en.pdf
English (PDF)
Download Published on: 13/03/2026